Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | B-T cell interactions in GvHD

Sara Deola • 30 Aug 2020
EBMT 2020
General

Sara Deola, MD, PhD, Sidra Medicine, Doha, Qatar, outlines interactions between B- and T-cells in graft-versus-host disease (GvHD), and discusses how B- and T-cell coupling can be used as a biomarker for GvHD incidence. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Sara Deola

Role of the microbiome in GvHD
3:35
Role of the microbiome in GvHD
Sara Deola • 1 Oct 2020
Immune-transcriptome signatures: a novel approach to understanding GvHD & GvT
6:31
Immune-transcriptome signatures: a novel approach to understanding GvHD & GvT
Sara Deola • 30 Aug 2020
Role of the microbiome in GvHD
3:35
Role of the microbiome in GvHD
Sara Deola • 30 Aug 2020

Related Videos

From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
2:58
From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
Iskra Pusic • 11 Sep 2026
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
3:46
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
Maher Salamoon • 8 Sep 2026
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
2:01
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
Michael Jain • 11 Sep 2026
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
1:46
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
Michael Jain • 11 Sep 2026
The content of VJHemOnc is intended for healthcare professionals